Find comprehensive information on Left Adrenal Nodule diagnosis, including ICD-10 codes (D35.0), clinical documentation requirements, adrenal incidentaloma management, and imaging findings (CT, MRI). Learn about hormonal evaluation for adrenal tumors, including aldosterone, cortisol, and catecholamines. Explore resources for healthcare professionals on adrenal mass workup, differential diagnosis, and treatment options for benign and malignant adrenal neoplasms. Understand the importance of accurate medical coding and documentation for left adrenal lesions.
Also known as
Hyperplasia of adrenal gland
Overgrowth of adrenal gland tissue, which can cause nodules.
Benign neoplasm of adrenal gland
Non-cancerous tumor in the adrenal gland.
Malignant neoplasm of adrenal gland
Cancerous tumor of the adrenal gland, sometimes appearing as a nodule.
Abnormal findings on adrenal imaging
Unspecified abnormal results from adrenal imaging studies, like nodules.
When to use each related code
| Description |
|---|
| Left adrenal nodule |
| Adrenal adenoma |
| Pheochromocytoma |
Coding left adrenal nodule without confirmatory imaging (CT/MRI) or biopsy can lead to inaccurate coding and denials.
Failing to code the correct laterality (left vs right) impacts data accuracy and reimbursement for procedures.
Distinguishing incidental findings from primary adrenal disease is crucial for accurate reporting and clinical management.
Patient presents with a left adrenal nodule, incidentally discovered on (imaging modality, e.g., abdominal CT, MRI) performed for (indication). The patient denies symptoms of adrenal hormone excess, including palpitations, weight gain or loss, hypertension, muscle weakness, easy bruising, or hirsutism. Review of systems is otherwise negative. Physical exam is unremarkable, with normal blood pressure and no palpable abdominal masses. The left adrenal nodule measures (size in mm) and demonstrates (imaging characteristics, e.g., homogenous, heterogeneous, calcifications) on imaging. Differential diagnosis includes adrenal adenoma, adrenal cortical carcinoma, pheochromocytoma, and metastasis. Initial laboratory evaluation will include serum electrolytes, cortisol, aldosterone, renin, and metanephrines to assess for hormonal hyperfunction. Further management will be determined based on hormonal evaluation and radiographic characteristics of the nodule, and may include repeat imaging, adrenal protocol CT, or referral to endocrinology for further evaluation and consideration of fine-needle aspiration or surgical excision. Patient education provided regarding adrenal nodules, incidentalomas, and the importance of follow-up. ICD-10 code D35.0 will be considered, pending laboratory results. CPT codes for the imaging study and laboratory tests will be documented separately.